IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement - 13/06/24
Doi : 10.1016/j.jinf.2024.106176
Bente Halvorsen a, b, Hans-Kittil Viermyr a, Thor Ueland a, b, c, Ellen L. Sagen a, Annika E. Michelsen a, b, Vigdis Bjerkeli a, 
The Nor-Solidarity Study Group
Anders A. Tveita d, e, Katerina N. Henriksen f, g, Trine Kåsine h, Anne Ma Dyrhol-Riise b, k, Marius Trøseid a, b, j, Tuva B. Dahl a, i, Pål Aukrust a, b, j, Ida Gregersen a, ⁎ a Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, 0027 Oslo, Norway
b Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway
c Thrombosis Research Center (TREC), Division of internal medicine, University hospital of North Norway, Tromsø Norway
d Department of Internal Medicine, Bærum Hospital, Vestre Viken Hospital Trust, 1346 Gjettum, Norway
e Division of Laboratory Medicine, Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway
f Department of Hematology, Oslo University Hospital, Oslo, Norway
g Hospital Pharmacies, South-Eastern Norway Enterprise, Oslo, Norway
h Department of Anaesthesia and Intensive Care Medicine, Oslo University Hospital, Oslo, Norway
i Department of Acute Medicine, Oslo University Hospital, Oslo, Norway
j Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway
k Department of Infectious Diseases, Oslo University Hospital, Ullevål, Oslo, Norway
⁎Correspondence to: Research Institute of Internal Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, N-0424 Oslo, Norway.Research Institute of Internal Medicine, Oslo University HospitalP.O. Box 4950 NydalenOsloN-0424Norway
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | IL-22 is increased in COVID-19 patients with severe outcome. |
• | IL-22 is associated with cardiac risk markers in hospitalized COVID-19 patients. |
• | High IL-22 is associated with risk of cardiac involvement during hospitalization. |
Plan
© 2024
The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 89 - N° 1
Article 106176- juillet 2024 Retour au numéro
Article précédent
- The modern face of esophageal candidiasis in an oncology center: Correlating clinical manifestations, endoscopic grade, and pathological data in 323 contemporary cancer patients
- Takahiro Matsuo, Ben S. Singh, Sebastian Wurster, Ying Jiang, Manoop S. Bhutani, Deyali Chatterjee, Dimitrios P. Kontoyiannis
- Neutralization activity of HCWs’ sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination
- Masayuki Amano, Yasuko Ichikawa, Shota Matsumoto, Nobuyo Higashi-Kuwata, Yuki Takamatsu, Shuzo Matsushita, Shinya Shimada, Hiroaki Mitsuya
Bienvenue sur EM-consulte, la référence des professionnels de santé.